Clossacillina [DCIT]
Clossacillina [DCIT] Brand names, Clossacillina [DCIT] Analogs
Clossacillina [DCIT] Brand Names Mixture
- No information avaliable
Clossacillina [DCIT] Chemical_Formula
C19H18ClN3O5S
Clossacillina [DCIT] RX_link
No information avaliable
Clossacillina [DCIT] fda sheet
Clossacillina [DCIT] msds (material safety sheet)
Clossacillina [DCIT] Synthesis Reference
No information avaliable
Clossacillina [DCIT] Molecular Weight
435.882 g/mol
Clossacillina [DCIT] Melting Point
No information avaliable
Clossacillina [DCIT] H2O Solubility
13.9 mg/L
Clossacillina [DCIT] State
Solid
Clossacillina [DCIT] LogP
2.274
Clossacillina [DCIT] Dosage Forms
Capsules (250 mg, 500 mg); Powder (125 mg/5 mL when reconstituted)
Clossacillina [DCIT] Indication
Used to treat infections caused by penicillinase-producing staphylococci, including pneumococci, group A beta-hemolytic streptococci, and penicillin G-sensitive and penicillin G-resistant staphylococci.
Clossacillina [DCIT] Pharmacology
Cloxacillin is a semisynthetic antibiotic in the same class as penicillin. Cloxacillin is for use against staphylococci that produce beta-lactamase.
Clossacillina [DCIT] Absorption
Well absorbed from the gastrointestinal tract.
Clossacillina [DCIT] side effects and Toxicity
Oral LD50 in rat and mouse is 5000 mg/kg. Intravenous LD50 in rat is 1660 mg/kg. Symptoms of overdose include wheezing, tightness in the chest, fever, itching, bad cough, blue skin color, fits, and swelling of face, lips, tongue, or throat.
Clossacillina [DCIT] Patient Information
Clossacillina [DCIT] Organisms Affected
Enteric bacteria and other eubacteria
![Clossacillina_[DCIT]](/images/rx/APRD00882.gif)
